Assessing exercise capacity in rheumatoid arthritis patients using a 6-minute step test

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of the 6-minute step test (6MST) as an alternative method to assess aerobic exercise capacity in patients with rheumatoid arthritis (RA). The research aims to address the limitations of the traditional bicycle ergometer test, which can be inconsistent and requires expensive equipment. By utilizing the 6MST, which is simpler and requires less space, the study seeks to provide a more accessible means of evaluating functional capacity for individualized rehabilitation planning. Patients diagnosed with RA will be assessed at Firat University Hospital, focusing on their ability to walk independently.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* RA patient
* Over 18 years of age
* 100 kilos or less
* Patients who can walk independently without an assistive device

Exclusion Criteria:

* History of serious heart and lung disease
* Presence of severe musculoskeletal and joint disorders that may interfere with the conduct of the test
* Arthroplasty or major operations on knee and hip joints
* Uncontrolled hypertension
* Inability to participate in physical tests involving walking and cycling

Where it's running

• Firat University
  Merkez, Elâzığ, Turkey (Türkiye) Recruiting

Study contacts

• Study coordinator: Havvagül Doğan
• Email: havvvaguldogan@gmail.com
• Phone: +904242370000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Heart Rate Variability and Rheumatoid Arthritis: What HRV Looks Like with RA

  This study checks whether continuous HRV data from an Oura ring can reflect RA disease activity in adults with RA.

  Recruiting University of Central Florida · Orlando, Florida · NCT07878975

• Discontinuing MTX or LEF in RA Patients on TNF Inhibitors

  This trial tests whether stopping methotrexate or leflunomide while continuing a TNF inhibitor is not worse for disease control in adults with rheumatoid arthritis.

  Recruiting Phase 4 Sint Maartenskliniek · Nijmegen, Gelderland and 3 other locations · NCT07802678

• FT839 therapy for autoimmune diseases

  This trial tests FT839, given alone or with rituximab, to see if it is safe and can help people with certain autoimmune diseases who have not responded to other treatments.

  Recruiting Phase 1/2 Fate Therapeutics · Fullerton, California · NCT07800871

• 24-Hour Movement and Atherosclerotic Risk in adults with rheumatoid arthritis

  This study tests how daily activity, sitting, and sleep relate to heart-related risk in adults with RA, using wearables and follow-up after a year.

  Recruiting São Paulo State University · Presidente Prudente, São Paulo · NCT07774507

• Integrative AI profiling of chronic RA pain

  This study tests whether an AI-driven multiomic and neurophysiological approach can help explain and predict persistent pain in adults with active rheumatoid arthritis.

  Recruiting 4th Military Clinical Hospital with Polyclinic, Poland · Wroclaw · NCT07769619

• Oxidative Stress and Heart Risk in People with Rheumatoid Arthritis

  This study tests whether certain markers of oxidative stress in people with rheumatoid arthritis are linked to subclinical atherosclerosis and arterial stiffness, which could relate to future heart disease risk.

  Recruiting University of La Laguna · Santa Cruz de Tenerife, Canary Islands · NCT07760662

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.